Karlin Daniel, Chief Medical Officer of Definium Therapeutics ($DFTX), sold shares four times on the open market over the past year, for a total of about $248,300. His most recent sale occurred on December 26, 2025. These transactions rank 7,983rd among 11,678 insiders by sale value, well below the average of $8.6 million across about 6.4 sales per seller. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | Definium Therapeutics, Inc. | $DFTX | Karlin Daniel | Chief Medical Officer | S | Common Shares | 8018 | $18.47 | 413,317.0000 | 98,509,279 | 1.90% | 0.01% |
| Feb. 3, 2026 | Definium Therapeutics, Inc. | $DFTX | Karlin Daniel | Chief Medical Officer | A | Common Shares | 150000 | $0.00 | 575,025.0000 | 98,509,279 | 35.29% | 0.15% |
| Dec. 26, 2025 | Definium Therapeutics, Inc. | $DFTX | Karlin Daniel | Chief Medical Officer | S | Common Shares | 5600 | $13.15 | 425,025.0000 | 98,509,279 | 1.30% | 0.01% |
| Sept. 25, 2025 | Definium Therapeutics, Inc. | $DFTX | Karlin Daniel | Chief Medical Officer | S | Common Shares | 7704 | $9.77 | 430,625.0000 | 75,368,359 | 1.76% | 0.01% |
| June 25, 2025 | Definium Therapeutics, Inc. | $DFTX | Karlin Daniel | Chief Medical Officer | S | Common Shares | 7848 | $6.80 | 438,329.0000 | 75,368,359 | 1.76% | 0.01% |
| March 25, 2025 | Definium Therapeutics, Inc. | $DFTX | Karlin Daniel | Chief Medical Officer | S | Common Shares | 6836 | $6.74 | 446,177.0000 | 75,368,359 | 1.51% | 0.01% |
| March 12, 2025 | Definium Therapeutics, Inc. | $DFTX | Karlin Daniel | Chief Medical Officer | A | Common Shares | 115000 | $0.00 | 453,013.0000 | 75,368,359 | 34.02% | 0.15% |
| Dec. 26, 2024 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 6643 | $7.43 | 338,013.0000 | 0 | 1.93% | 0.00% |
| Sept. 25, 2024 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 6871 | $5.98 | 344,656.0000 | 0 | 1.95% | 0.00% |
| June 25, 2024 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 6925 | $7.22 | 351,527.0000 | 0 | 1.93% | 0.00% |
| March 25, 2024 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 6578 | $9.50 | 358,452.0000 | 0 | 1.80% | 0.00% |
| Feb. 27, 2024 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 26, 2023 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 6774 | $3.63 | 365,030.0000 | 0 | 1.82% | 0.00% |
| Sept. 25, 2023 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 3678 | $3.57 | 375,044.0000 | 0 | 0.97% | 0.00% |
| Sept. 25, 2023 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 3240 | $3.58 | 371,804.0000 | 0 | 0.86% | 0.00% |
| June 27, 2023 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 2963 | $3.21 | 378,722.0000 | 0 | 0.78% | 0.00% |
| June 27, 2023 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 3820 | $3.19 | 381,685.0000 | 0 | 0.99% | 0.00% |
| March 14, 2023 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | A | Common Shares | 125000 | $0.00 | 385,505.0000 | 0 | 47.98% | 0.00% |
| March 1, 2023 | Definium Therapeutics, Inc. | $DFTX | Karlin Dan | Chief Medical Officer | S | Common Shares | 3577 | $3.51 | 260,505.0000 | 0 | 1.35% | 0.00% |